Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) reported Non-Current Assets of $6.7 million for Q1 2026, up 28.92% year-over-year from $5.2 million in Q1 2025, and up 81.73% quarter-over-quarter from $3.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Non-Current Assets data on file, last reported at $6.7 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $6.7 million, up 28.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.6 million (down 22.14% YoY), and the FY2025 annual result was $3.7 million, down 39.17% from the prior year.
- Non-Current Assets rose to $6.7 million in Q1 2026 per TECX's latest filing, from $3.7 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $8.5 million in Q4 2023 and troughed at $510000.0 in Q1 2024.
- A 5-year average of $4.7 million and a median of $4.5 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets slumped 91.14% in 2024, then jumped 916.86% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $4.0 million in 2022, then jumped by 113.36% to $8.5 million in 2023, then fell by 28.97% to $6.0 million in 2024, then slumped by 39.17% to $3.7 million in 2025, then surged by 81.73% to $6.7 million in 2026.
- Business Quant data shows TECX's Non-Current Assets at $6.7 million in Q1 2026, $3.7 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 39.71 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 6.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.69 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 4.47 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Mar 31, 2024 | 510,000.00 |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 4.16 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 4.80 Mn |
| Jun 30, 2021 | 4.58 Mn |